Hikma Pharmaceuticals PLC (LSE:HIK) - Share price - Overview

Stock Report

Hikma Pharmaceuticals PLC HIK

Last Price
GBX1,622.50

Day Change
8.00|0.50%

As of 23/07/2018
08:40:38 BST | GBX
Minimum 15 Minutes Delay.

Last Close1,614.50p
Day Range1,609.00 - 1,630.00
Mkt Cap3.90Bil
52-Wk Range814.20 - 1,650.00
Yield %0.00
ISINGB00B0LCW083
Volume27,735
P/E-449.45
P/S2.01
P/CF8.79

Share Price

Total Returns 20/07/2018

 Chg (%)  
More ...
Hikma Pharmaceuticals PLC14.71 
FTSE 100 TR GBP0.80
 
Financials
201520162017
More ...
Income Statement
Turnover1,440.001,950.001,936.00
Operating Profit381.00309.00323.00
Net Profit254.00158.00-839.00
Reported EPS1.260.66-3.51
Balance Sheet
Current Assets1,360.001,448.001,574.00
Non Current Assets1,237.002,915.001,814.00
Total Assets2,597.004,363.003,388.00
Current Liabilities592.00918.00797.00
Total Liabilities1,245.001,952.001,860.00
Total Equity1,352.002,411.001,528.00
Cash Flow
Operating Cash Flow366.00293.00443.00
Net Change in Cash281.00-383.0072.00

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
30/05/2018PurchaseMr. Sigurdur Olafsson1,309.1920,000261,838.00
22/05/2018PurchaseMr. John Julius Castellani1,376.951,00013,770.00
15/05/2018Exercise of OptionMr. Mazen Samih Taleb Darwazah0.0020,0000.00
15/05/2018Exercise of OptionMr. Said Darwazah0.0027,0000.00

Company Profile

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Next Event 15/08/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)1.71
PEG (E)2.94
ROCE-26.52
Op Mrgn0.17
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Date25/08/1706/04/18
Ex-Div24/08/1705/04/18
Paid22/09/1724/05/18
Amnt8.5016.54
Directors
More ...
Executive Director, Vice ChairmanMr. Mazen Samih Taleb Darwazah
Executive Director, ChairmanMr. Said Darwazah
Non-Executive DirectorMohammed Ali Khaldoun S Al-Husry
Non-Executive DirectorNina Henderson
Non-Executive DirectorMr. Patrick Butler
Non-Executive DirectorMr. John Julius Castellani
Non-Executive DirectorMr. Robert Pickering
Non-Executive DirectorDr. Ronald L Goode
Non-Executive DirectorDr. Pamela J Kirby
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.